STRATEC Biomedical Financial Overview
STRATEC Biomedical's market cap is currently €269.25M. The company's EPS TTM is €0.13; its P/E ratio is 16.81; and it has a dividend yield of 2.71%. STRATEC Biomedical is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
